ArticleMycotoxin research2026
Fusarium infection in malting barley drives trichothecene transfer and transformation during brewing process, impacting beer safety and composition.
Article in Mycotoxin research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium contamination in malting barley poses a constant threat of mycotoxin exposure in brewing. However, the chemical transformations of trichothecenes toxins during processing and the broader impact of fungal contamination on beer quality are insufficiently understood. In this study, we inoculated barley grains with Fusarium culmorum to track the behavior of deoxynivalenol (DON) and its conjugates, deoxynivalenol-3-glucoside (DON-3G) and 3-acetyldeoxynivalenol (3-AcDON), through a controlled malting and brewing sequence. Quantitative LC-MS/MS and qPCR analyses revealed extensive fungal activity and toxin formation in malt, reaching 1,054 µg kg⁻¹ DON and 4,352 µg kg⁻¹ DON-3G, respectively. Mashing and lautering facilitated the release of matrix-bound toxins, whereas fermentation represented the key stage for biochemical transformation. During this phase, yeast metabolism markedly increased free DON through the hydrolysis of DON-3G and deacetylation of 3-AcDON. During maturation, a partial re-glycosylation of DON was observed. Despite toxin conversions, the final Fusarium infected batch (FIB) still contained substantial residues of the original toxins load in malt: 99% of DON, 50% of DON-3G, and 84% of 3-AcDON. Fusarium likewise affected chemical and sensory quality of beer: beer from infected kernels showed darker color, elevated soluble nitrogen, and a higher Thiobarbituric Acid Index, pointing toward intensified Maillard reaction activity. Untargeted FT-ICR-MS and LC-ToF-MS analysis confirmed infection-driven shifts in the beer’s molecular composition, revealing elevated Maillard-derived compounds and a distinct biochemical imprint of infection marked by fungal metabolites such as hydroxytrichodiene and host-defense conjugates including cinnamoyl-serotonin derivatives. Our findings show that F. culmorum infection affects both consumer safety of beer and the fundamental (bio)chemistry underlying its composition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.